|View printer-friendly version|
|Array BioPharma to Present Data From Anti-Cancer Program at the American Society of Clinical Oncology Annual Meeting|
BOULDER, Colo., May 12 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that a scientific poster will be presented at the American Society of Clinical Oncology Annual Meeting in Orlando, Florida.
Poster: "Validation and Use of a Biomarker for Clinical Development of the MEK 1 / 2 Inhibitor ARRY-142886 (AZD6244)" Abstract # 3075
Event: American Society of Clinical Oncology Annual Meeting
Date: Sunday, May 15, 2005
Time: 8 a.m. - 12:00 noon Eastern Time
Location: Orange County Convention Center, Orlando, Florida
A PDF of the poster will be available for viewing on Array's website at www.arraybiopharma.com on Monday, May 16.
About Array BioPharma:
Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.